o2h Chaitime
-
Empowering early-stage biotech: The o2h kickstarter boost
-
Is investing in SEIS ventures risky?
-
Christmas Special – Jingle Chai – Fireside Chat with Sir Mene Pangalos
-
Countdown to Tax Year End – Britain’s Startup Ecosystem
-
Next Wave of Britain’s Most Exciting Biotechs- From Small Molecule to Quantum Computing…
More about Chaitime
more about ChaiTime
Season
Topics
- culture and community
- discovery
- technology
- ventures
No data found
Empowering early-stage biotech: The o2h kickstarter boost
Dr Janette Thomas,
Vid Stojevic,
Neil Benson,
Beth J Hoffman,
Jason Rutt,
Sunil Shah,
Is investing in SEIS ventures risky?
Fred Soneya,
Dom Raban,
Thelma Zablocki,
Alice MacGown,
Sunil Shah,
Christmas Special – Jingle Chai – Fireside Chat with Sir Mene Pangalos
Sir Mene Pangalos ,
Sunil Shah (moderator)
Biotech and IPOs
Sarah Howell ,
Tiffany Thorn ,
Sharon Shacham ,
Peter Rands,
Sunil Shah (moderator)
Countdown to Tax Year End – Britain’s Startup Ecosystem
Patrick Beldon ,
Martin Taylor ,
Mark Brownridge ,
Kirsty Greenwood (moderator)
Has the Pandemic been a tailwind for Biotech investing?
Sam Fazeli,
Sunil Shah (moderator)
The Drug Hunters – Christmas Special
Peter Hamley ,
Christopher Smith ,
Hemal Soni ,
Karin Briner ,
Sunil Shah (moderator)
Next Wave of Britain’s Most Exciting Biotechs- From Small Molecule to Quantum Computing…
Dr. Tim Sparey ,
Dr. Myriam Ouberai ,
Dr. Vid Stojevic ,
Dr Andy Richards CBE (moderator)
Keeping the Technology on the Fast-Track to Transform Healthcare
Stephanie Campbell ,
Natalia Mateu ,
Toby Clark ,
Craig Townsend (moderator)
Using Knowledge Intensive Investing to Spur the Growth of UK Biotech
Dr Andrew Woodland ,
Mark Brownridge ,
Dr Martin Hall ,
Kirsty Greenwood (moderator)
Research in Rare Diseases – The Scientists, New Technology and The Patients
Michael Binks,
Nicola Miller ,
Tim Guilliams ,
Prashant Shah (moderator)
The Virtualization of Biotechnology to Deliver Superior Investor Returns
Dr. Matt Cooper ,
Dr. Harren Jhoti ,
Professor Chas Bountra OBE ,
Sunil Shah (moderator)
From PHD to CEO, Entrepreneur War Stories from the Front Line
Myriam Ouberai ,
William Bateman ,
Oliver Armitage ,
Fiona Neilsen ,
Prashant Shah (moderator)
AI and Drug Discovery
Jackie Hunter ,
Hannah Sore ,
Tina Larson ,
Dr. Jerome Wicker ,
Sunil Shah (moderator)
Learning the Lessons of Building Grapeshot and Exit to Oracle
John Snyder ,
Max Bautin ,
Sunil Shah (moderator)
Academic Spinouts – A UK and US Perspective…
Peter Lane ,
Dr. Christine Martin ,
Vinit Nijhawan ,
Sunil Shah (moderator)
The Best of American and British Entrepreneurs to Build a Successful Biotech Therapeutic Venture
Jennifer Petter ,
Rosamond Deegan ,
Sunil Shah (moderator)
The Emerging World of Digital Therapeutics
Nigel Pitchford ,
Guillem Singla Buxarrais ,
Shamus Husheer ,
Patrick Beldon ,
Sunil Shah (moderator)
Building a Diversified Portfolio Post Covid19
Madison Faller ,
Luke Hakes ,
Sunil Shah (moderator)
Faster Cancer Drugs to Patients
Niall Martin ,
Raj Chopra ,
Chris Torrance ,
Ruth Plummer ,
Ashok Venkitaraman (moderator)
One-on-One Interview with the Author of “Building an Unconventional Biotech”
Blaise Lippa ,
Sunil Shah (moderator)
Antibiotic Resistance – The Fight for Humanity
Paul Finn ,
Ajay Mistry ,
Ken Bradley ,
Ankit Mahadevia ,
Small Biotech and Big Pharma
Catherine Beech OBE ,
Pete Adamson,
Sunil Shah (moderator)
Britain’s Most Exciting Human Health Companies
Sarah Howell ,
Peter Rands ,
Ruchi Sharma ,
Szabolcs Nagy ,
Andy Richards (moderator)
How to Build a Tech Business – From Funding, to Launch, to Exit!
Kamil Tamiola ,
Ray Anderson,
Mark Warne ,
Max Bautin,
Fiona Nielsen ,
Craig Townsend (moderator)
Innovate from Your Sofa
Lekha Washington ,
Professor Christoph Loch ,
Chris Heron,
Karin Briner ,
Prashant Shah (moderator)
Early Stage Investing in a Post COVID19 Pandemic Environment
Deepali Nangia ,
Goncalo de Vasconcelos ,
Kieran Murphy ,
Peyman Gifani ,
Sanjeev Gordhan ,
Steve Thurlby,
Sunil Shah (moderator)
o2h Chaitime Webinars
o2h chatime is an exciting webinar series which covers a range of interesting topics from drug discovery therapeutics and investing, to arts and culture.
The webinars feature popular panelists ranging from top scientists, prominent roles in pharmaceuticals, founders of start-ups to well known performance artists and architects.
Register for invitations to our upcoming webinars and brew up your Chai!
